Tilray, Inc. IPO Research Information

Tilray, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Tilray, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Tilray, Inc.	TLRY - NASDAQ	$14.00-$16.00	$17.00	$23.05	9.0 million	7/19/2018
Underwriter(s): Cowen, Roth Capital, Northland Capital
Co-Manager(s):
Industry: Consumer
Filing(s): Filed 2018-06-20 Terms Added 2018-07-09

Tilray, Inc. Quote & Chart - Click for current quote - TLRY

About Tilray, Inc. (adapted from Tilray, Inc. prospectus):
They are pioneering the future of medical cannabis research, cultivation, processing and distribution globally, and we intend to become a leader in the adult-use cannabis market in Canada once legalized.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "TLRY" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.